| ²é¿´: 654 | »Ø¸´: 3 | ||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||||
yan1302½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÈçºÎÀí½âstability-indicating
|
|||
|
ÔÚÒ©Æ·Îȶ¨ÐÔ¿¼²ìÖУ¬ÒªÇóʹÓÃָʾÎȶ¨ÐԵķÖÎö·½·¨(stability-indicating analytical method). ÄÇôÎÒÃÇÓ¦¸ÃÈçºÎÀí½âstability-indicating ÄØ£¿ÎÒÔÚÍøÉÏ¿´ÕâÑùÒ»¶Î»°FDA defines stability-indicating assay as an analytical method that accurately quantitates the active ingredients without interference from degradation products, process impurities, excipients or other potential impurities¡£´ÓÕâ¶Î»°¿´FDA½«Ö¸Ê¾Îȶ¨ÐԵķÖÎö·½·¨¶¨ÒåΪÄܹ»×¼È·¶¨Á¿·ÖÎö»îÐԳɷֶø²»Êܽµ½â²úÎï¡¢¹¤ÒÕÔÓÖÊ¡¢¸¨ÁÏ»òÆäËûDZÔÚÔÓÖʸÉÈŵķÖÎö·½·¨¡£ÄÇôÇëÎÊ´ó¼ÒÊÇÈçºÎÀí½âstability-indicatingµÄÄØ£¿ÄÄЩ·½·¨ÐèÒªÊÇָʾÎȶ¨ÐԵģ¿ÓÖÈçºÎÖ¤Ã÷·ÖÎö·½·¨Ö¸Ê¾Îȶ¨ÐÔµÄÄÜÁ¦µÄ£¿ [ Last edited by yan1302 on 2006-12-25 at 08:44 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
²Î¿¼¼ÛÖµ |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ
ÒѾÓÐ13È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ11È˻ظ´
ΪʲôÖйú´óѧ¹¤¿Æ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
cpucf
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
ÏàÓÉÐÄÉú£¬¾³ËæÐÄת
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ¹ó±ö: 3.47
- ½ð±Ò: 6293
- ºì»¨: 3
- Ìû×Ó: 7872
- ÔÚÏß: 92.9Сʱ
- ³æºÅ: 53526
- ×¢²á: 2004-09-18
- רҵ: Ò©¼Áѧ

2Â¥2006-12-13 19:27:32
¹ãÖ®
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 2443.5
- ºì»¨: 1
- Ìû×Ó: 334
- ÔÚÏß: 246.9Сʱ
- ³æºÅ: 82545
- ×¢²á: 2005-07-25
- רҵ: ÖÊÆ×·ÖÎö
|
ÔÁÏÒ©£¨»ò³ÉÆ·£©ÔÚÖÆ±¸ºÍÖü´æÆÚ¼ä¿ÉÄֽܷ⣬ÔÚ½¨Á¢¹æ¸ñÒÔ¼°¼ì²â·½·¨Ê±Ó¦¸ÃÓÐËù¿¼ÂÇ¡£»ùÓÚÐí¶àÒ©Îï±¾ÉíµÄ¸´ÔÓÐÔ£¬²¢ÎÞµ¥Ò»µÄµÄÎȶ¨ÐÔÖ¸±ê·ÖÎö»ò²ÎÊý¿ÉÃè»æÈ«²¿Ò©Îï»ò³ÉÆ·µÄÎȶ¨ÐÔ¡£Òò´Ë£¬Ó¦¸ù¾ÝÒ©Îï±¾ÉíÄⶨÎȶ¨ÐÔÖ¸±ê·ÖÎö·½·¨£¬ÓÃÒÔ̽ÌÖÒ©ÎïÆ·Öʵı仯£¬Ðè²ÉÓÃÄÄЩ²âÊÔÔòÈ¡¾öÓÚÒ©Îï±¾ÉíµÄÌØÐÔ¡£ ÔÚÒ©ÎïÑо¿µÄÔçÆÚ¿ªÕ¹Îȶ¨ÐÔ¿Á¿ÌʵÑéÊÇÊܹÄÀøµÄ£¬ÒòΪÕâЩÑо¿ÌṩµÄ×ÊÁ϶ÔʵÑéÑ¡ÔñÎȶ¨ÐÔʵÑé·ÖÎö·½·¨ÊÇÏàµ±ÖØÒªµÄ¡£Ç¿ÆÈ½µ½âʵÑéÊÇ·ÖÎö·½·¨µÄstability-indicatingÑéÖ¤µÄÒ»¸öÖØÒª²¿·Ö¡£ÀíÂÛÉÏÀ´½²£¬Îȶ¨ÐÔʵÑé¼ìÑé·½·¨ÎÞÂÛÊÇ·ñÓë³ÉÆ··ÅÐмìÑé·½·¨Ò»Ö£¬¶¼±ØÐë½øÐÐÇ¿ÆÈ½µ½âʵÑ飬ÒÔÖ¤Ã÷¸Ã·½·¨ÊÇstability-indicating¡£¼È±ãÊÇÒ©µä·½·¨£¬Ò²±ØÐëÕâÑù×ö¡££¨Èç×ö£ºÒ©ÎïµÄÓ°ÏìÒòËØÊµÑé·ÖÎö£¬±ÈÈçÇ¿ËáÇ¿¼îÆÆ»µÊµÑéµÈ£¬Ö÷ÒªÊÇ¿¼²ìÒ©ÎïÔÚ²»Í¬Ìõ¼þϵÄÎȶ¨Çé¿ö£© ¿ÉÒԲο¼¡¶Stability-Indicating HPLC Methods for Drug Analysis¡·£¨¿ÉϧÎÒûÓÐÕâ±¾Ê飬ÄÄλÓеģ¬ÄÜ·ñ¹²Ïí°¡£¿£© [ Last edited by ¹ãÖ® on 2006-12-24 at 22:40 ] |
3Â¥2006-12-24 22:35:08
yan1302
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 735.8
- ºì»¨: 1
- Ìû×Ó: 148
- ÔÚÏß: 29.4Сʱ
- ³æºÅ: 214507
- ×¢²á: 2006-03-10
- ÐÔ±ð: GG
|
¸Ðл3Â¥µÄ»Ø´ð¡£FDA¸øÌ¨ÍåDeltaºÏ³ÉµÄ¾¯¸æÐÅÓйØÎȶ¨ÐÔÊÔÑéµÄÔÎÄÊÇÕâÑùµÄ£º Stability-indicating methods were not used in the stability testing program for [ ] You response indicates that you will use stability indicating methods in the future stability testing of [ ]. However, it fails to indicate whether you are currently using stability indicating methods in your stability program and did not provide a timeframe for beginning the use of stability indicating methods. The test procedures used in stability testing should be validated and be stability indicating. please provide documentary evidence that you are currently using stability indicating methods for all stability testing of [ ] and any other API manufactured for US market. ÁíÍ⣬·ÖÏíһƪÓйظÃÖ÷ÌâµÄÎÄÕ¡£ [ Last edited by yan1302 on 2006-12-25 at 08:46 ] |
4Â¥2006-12-25 08:41:14













»Ø¸´´ËÂ¥